StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Calidi Biotherapeutics cash

Cash and short-term investments held at the end of each period.

Calidi Biotherapeutics's cash was $4.07M at Jun 30, 2026. For fiscal 2025 it was $5.60M, down 42.9% from the year before. The highest annual figure on record is $9.81M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.60M-42.9%
FY2024Dec 31, 2024$9.81M+352.7%
FY2023Dec 31, 2023$2.17M+267.3%
FY2022Dec 31, 2022$590.00K-73.6%
FY2021Dec 31, 2021$2.24M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.07M-22.9%
Q1 FY2026Mar 31, 2026$6.63M-37.2%
Q4 FY2025Dec 31, 2025$5.60M-42.9%
Q3 FY2025Sep 30, 2025$10.38M+446.9%
Q2 FY2025Jun 30, 2025$5.28M+531.5%
Q1 FY2025Mar 31, 2025$10.56M+824.0%
Q4 FY2024Dec 31, 2024$9.81M+352.7%
Q3 FY2024Sep 30, 2024$1.90M-81.7%
Q2 FY2024Jun 30, 2024$836.00K-63.4%
Q1 FY2024Mar 31, 2024$1.14M+0.5%
Q4 FY2023Dec 31, 2023$2.17M+267.3%
Q3 FY2023Sep 30, 2023$10.37M+3355.0%
Q2 FY2023Jun 30, 2023$2.29M+595.2%
Q1 FY2023Mar 31, 2023$1.14M+90.3%
Q4 FY2022Dec 31, 2022$590.00K-73.6%
Q3 FY2022Sep 30, 2022$300.00K-74.9%
Q2 FY2022Jun 30, 2022$328.84K+246.2%
Q1 FY2022Mar 31, 2022$597.52K–
Q4 FY2021Dec 31, 2021$2.24M–
Q3 FY2021Sep 30, 2021$1.20M–
Q2 FY2021Jun 30, 2021$95.00K–
Q1 FY2021Mar 23, 2021$0–

More Calidi Biotherapeutics figures

See a number that looks wrong?